Global 3D Bioprinting Market (Size of $98.6 Million in 2015) to Witness 35.9% CAGR During 2016 – 2022

  • Published: November 2016

The global 3D bioprinting market generated revenue of $98.6 million in 2015 and is expected to advance at a CAGR of 35.9% during the forecast period. Increasing demand for organ and tissue transplants and advancements in technology are the two major factors driving the growth of the market. Globally, the demand for tissues and organs for transplantation is increasing; however, it is not being met due to the paucity of organ donors. This, in turn, is driving the adoption of the 3D bioprinting technology in tissue engineering.

Insights into Market Segments

3D bioprinting is widely used for tissue and organ regeneration, 3D cell culture, pharmaceutical, and other applications. Among these, tissue and organ regeneration is expected to continue being the largest revenue generating category in the 3D bioprinting market in the near future, owing to the increasing application of the technology in the cosmetic industry across the globe.

Among various technologies, pneumatic extrusion-based 3D bioprinting is expected to witness the highest demand in the 3D bioprinting market during the forecast period. This can be mainly ascribed to the high-resolution quality provided by the technology. Syringe-based 3D bioprinting technology is the largest revenue generator in the market and accounted for more than 60% share in 2015.

Geographically, North America accounts for the largest share in the 3D bioprinting market, mainly driven by technological advancements and increasing research and development (R&D) activities in the region. Further, the U.S. leads the regional market. Increasing investments by market players and technological developments in 3D bioprinting are the major factors responsible for the growth of the market in the country.

Increasing Investments in R&D to Boost Market Growth

Several pharmaceutical companies, along with academic institutes and laboratories, are making investments for the R&D of 3D bioprinters. Besides, increasing regulatory compliance with respect to the use of the technology in drug discovery processes is supporting the market growth. Growing stem cell research and increasing adoption of 3D bioprinting in the cosmetic industry are also expected to create ample growth opportunities for the players in the 3D bioprinting market. However, the high cost of 3D bioprinters and lack of skilled professionals are the major barriers to the growth of the market.

Competitive Landscape of Market

Organovo Holdings Inc., CELLINK, EnvisionTEC, BioBots, Cyfuse Biomedical K.K., Aspect Biosystems Ltd., 3D Bioprinting Solutions, Ourobotics, Advanced Solutions Inc., GeSiM GmbH, Bio3D Technologies, 3Dynamic Systems Ltd., Nano3D Biosciences Inc., Poietis, regenHU Ltd., and Aerotech Inc. are some of the major players operating in the global 3D bioprinting market.


Market Segmentation by Technology

  • Syringe Based
  • Pneumatic Extrusion Based
  • Inkjet Based
  • Laser Based
  • Others

Market Segmentation by Application

  • Tissue and Organ Regeneration
  • 3D Cell Culture
  • Pharmaceutical
  • Others

Market Segmentation by Geography

North America 3D Bioprinting Market

  • By Technology
  • By Application
  • By Country – U.S. and Rest of North America

Europe 3D Bioprinting Market

  • By Technology
  • By Application
  • By Country – Germany, France, U.K., and Rest of Europe

Asia-Pacific (APAC) 3D Bioprinting Market

  • By Technology
  • By Application
  • By Country – Japan, China, and Rest of APAC

Rest of the World (RoW) 3D Bioprinting Market

  • By Technology
  • By Application